RxDoctor Payments Data

Sara Christie

Family · Greenville, SCNPI 1740641877

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $208,378 of the $229,199 with a category attached, or 90.9%. Galderma Laboratories, L.p. accounts for 99.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $85,295 and has fallen 51.6% since, to $41,317 in 2025. Among family clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$229,199in general payments, 2019–2025

Across 324 payments — averaging $707.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$229K
  • AbbVie$384
  • Amgen$58
  • Amarin Pharma, Inc.$40
  • Novo Nordisk$21
  • Takeda Pharmaceuticals U.S.A., Inc.$20

What the payments were for

  • Speaking & faculty fees$208,37891%
  • Travel & lodging$17,4378%
  • Food & beverage$3,3841%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$229,199 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina →

Other family in Greenville

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →